Literature DB >> 29335603

In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice.

Haibo Zhou1, Junlai Liu2,3,4, Changyang Zhou1,3, Ni Gao1,3, Zhiping Rao1,3, He Li1,3, Xinde Hu1,3, Changlin Li1, Xuan Yao1, Xiaowen Shen1, Yidi Sun5, Yu Wei1, Fei Liu1,3, Wenqin Ying1, Junming Zhang1, Cheng Tang1,3, Xu Zhang1, Huatai Xu1, Linyu Shi1, Leping Cheng1, Pengyu Huang6, Hui Yang7.   

Abstract

Despite rapid progresses in the genome-editing field, in vivo simultaneous overexpression of multiple genes remains challenging. We generated a transgenic mouse using an improved dCas9 system that enables simultaneous and precise in vivo transcriptional activation of multiple genes and long noncoding RNAs in the nervous system. As proof of concept, we were able to use targeted activation of endogenous neurogenic genes in these transgenic mice to directly and efficiently convert astrocytes into functional neurons in vivo. This system provides a flexible and rapid screening platform for studying complex gene networks and gain-of-function phenotypes in the mammalian brain.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29335603     DOI: 10.1038/s41593-017-0060-6

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  71 in total

Review 1.  Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics.

Authors:  Marliette R Matos; Seok-Man Ho; Nadine Schrode; Kristen J Brennand
Journal:  Mol Cell Neurosci       Date:  2020-07-23       Impact factor: 4.314

Review 2.  In vivo functional screening for systems-level integrative cancer genomics.

Authors:  Julia Weber; Christian J Braun; Dieter Saur; Roland Rad
Journal:  Nat Rev Cancer       Date:  2020-07-07       Impact factor: 60.716

3.  RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.

Authors:  Katelin E Ahlers-Dannen; Mackenzie M Spicer; Rory A Fisher
Journal:  Mol Pharmacol       Date:  2020-02-03       Impact factor: 4.436

Review 4.  Live-Animal Epigenome Editing: Convergence of Novel Techniques.

Authors:  J Antonio Gomez; Ulrika Beitnere; David J Segal
Journal:  Trends Genet       Date:  2019-05-22       Impact factor: 11.639

Review 5.  In vivo locus-specific editing of the neuroepigenome.

Authors:  Yun Young Yim; Collin D Teague; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2020-07-23       Impact factor: 34.870

6.  Recent advances of genome editing and related technologies in China.

Authors:  Wen Sun; Haoyi Wang
Journal:  Gene Ther       Date:  2020-08-03       Impact factor: 5.250

Review 7.  Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing.

Authors:  M A Artyukhova; Y Y Tyurina; C T Chu; T M Zharikova; H Bayır; V E Kagan; P S Timashev
Journal:  Free Radic Biol Med       Date:  2019-06-12       Impact factor: 7.376

Review 8.  Cancer CRISPR Screens In Vivo.

Authors:  Ryan D Chow; Sidi Chen
Journal:  Trends Cancer       Date:  2018-03-30

Review 9.  In vivo epigenome editing and transcriptional modulation using CRISPR technology.

Authors:  Cia-Hin Lau; Yousin Suh
Journal:  Transgenic Res       Date:  2018-10-04       Impact factor: 2.788

Review 10.  Animal models built for women's brain health: Progress and potential.

Authors:  Kathleen E Morrison
Journal:  Front Neuroendocrinol       Date:  2020-09-19       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.